CDC Innovative Approaches to Prevent, Find, Cure Tuberculosis in High-Burden Settings - LOI

Sponsor Deadline: 

Feb 3, 2020

Internal Deadline: 

Jan 10, 2020

Letter of Intent Deadline: 

Feb 3, 2020

Sponsor: 

Centers for Disease Control and Prevention Center for Global Health

UI Contact: 

CDC: Develop, Implement, and Evaluate Evidence-based, Innovative Approaches to Prevent, Find, and Cure Tuberculosis in High-Burden Settings
RFA-GH-20-001
Grants.gov  https://www.grants.gov/web/grants/view-opportunity.html?oppId=323140

Mandatory Letter of Intent due 2/3/2020
Application due to the CDC 3/3/2020

(p. 4 and p. 18)  Eligible applicant institutions may submit only one application. Because this CDC solicitation is limited regarding the number of applications that may go forward from the University, please refer to this link on the UIowa Limited Submissions process https://uiowa.infoready4.com/#competitionDetail/1759773  If you wish to apply to a program that limits the number of applications allowed per institution, please email a one-page abstract about your proposal, a brief CV or biosketch, along with a link to the program of interest, to Cheryl Ridgeway cheryl-a-ridgeway@uiowa.edu in the Office of the Vice President for Research with a cc to the Division of Sponsored Programs  dsp@uiowa.edu as soon as possible.  If we receive multiple abstracts in response to a given solicitation, a review will be conducted to select the applicant to submit on behalf of the University of Iowa.

The purpose of this Notice of Funding Opportunity NOFO is to develop, implement, evaluate evidence-based and innovative approaches to:

  • prevent TB infection, disrupt TB transmission, and halt progression of TB disease in high-burden settings;
  • find TB infection and TB disease in all populations, including those most vulnerable (i.e., children, displaced persons, health care workers, economically disadvantaged, PLHIV, persons with other co-morbid conditions [alcohol use disorders, diabetes mellitus, persons who use illicit substances, undernourished] and elderly);
  • optimize treatment for TB infection, TB disease, TB/HIV, and MDR TB through new treatment and adherence modalities;
  • enhance and strengthen the use of routinely collected data to monitor, evaluate, and improve TB program performance; and
  • implement operations research (i.e., local solutions for local problems) for broader

Categories: 

Keywords: